DexCom, Inc. (DXCM) Financials
Key financial figures for DexCom, Inc. (Q2 2026).
DexCom reported Q2 2026 revenue of $1.308 billion, up 13% year-over-year (12% organic), with GAAP diluted EPS of $0.64 and non-GAAP diluted EPS of $0.70, and raised full-year 2026 revenue guidance to $5.18-$5.25 billion. Total revenue of $1.308 billion, up 13% year-over-year on a reported basis and 12% on an organic basis. U.S. revenue of $933.4 million, up 11% year-over-year; international revenue of $375.0 million, up 19% year-over-year (16% organic). GAAP gross profit of $830.0 million, or 63.4% of revenue, up from 60.1% in Q2 2025; non-GAAP gross margin of approximately 64%. GAAP operating income of $318.3 million (24.3% of revenue, up 590 basis points year-over-year); non-GAAP operating income of $328.3 million (25.1% of revenue). On the outlook: Full-year 2026 revenue guidance raised to $5.18 billion to $5.25 billion (11% to 13% growth), with non-GAAP gross margin of approximately 64%, non-GAAP operating margin of approximately 23.5% to 24%, and adjusted EBITDA margin of approximately 31.5% to 32%. Figures are for Q2 2026, as DexCom, Inc. reported them.
- Revenue
- $1.3B
- Net Income
- $249M
- EPS
- $0.65
- Total Assets
- $6.5B
- Operating Cash Flow
- $269M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | $1.3B | $249M | $0.64 | 24.33% | $185M |
| Q1 FY2026 | $1.2B | $200M | $0.51 | 21.42% | $449M |
| Q4 FY2025 | $1.3B | $267M | $0.68 | 25.64% | $192M |
| Q3 FY2025 | $1.2B | $284M | $0.70 | 20.05% | $579M |
| Q2 FY2025 | $1.2B | $180M | $0.45 | 18.37% | $209M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $4.7B | $836M | $2.09 | 19.56% | $1.1B |
| FY2024 | $4.0B | $576M | $1.42 | 14.88% | $631M |
| FY2023 | $3.6B | $542M | $1.30 | 16.5% | $512M |
Frequently asked questions
What was DexCom, Inc.'s revenue last quarter?
DexCom, Inc. reported revenue of $1.31 billion for Q2 FY2026, up 13.1% from the same period a year earlier.
Is DexCom, Inc. profitable?
Yes. DexCom, Inc. reported net income of $249.1 million for Q2 FY2026, a net margin of 19.04% on revenue.
How has DexCom, Inc.'s margin trended?
Operating margin was 24.33% in Q2 FY2026, compared with 18.37% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did DexCom, Inc. generate?
DexCom, Inc. generated free cash flow of $184.5 million in Q2 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for DexCom, Inc. on SentiSense, with up to forty quarters and twenty fiscal years of history.